Colgate-Palmolive (NYSE:CL) Plans $0.45 Quarterly Dividend

Colgate-Palmolive (NYSE:CL) declared a quarterly dividend on Thursday, June 10th, RTT News reports. Stockholders of record on Wednesday, July 21st will be given a dividend of 0.45 per share on Monday, August 16th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.15%.

Shares of CL stock opened at $83.60 on Friday. The company has a current ratio of 1.01, a quick ratio of 0.64 and a debt-to-equity ratio of 11.42. The firm has a market cap of $70.72 billion, a P/E ratio of 26.97, a price-to-earnings-growth ratio of 4.26 and a beta of 0.61. The stock’s 50 day moving average is $81.83. Colgate-Palmolive has a 52 week low of $71.21 and a 52 week high of $86.41.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Thursday, April 29th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.79 by $0.01. The firm had revenue of $4.34 billion for the quarter, compared to the consensus estimate of $4.28 billion. Colgate-Palmolive had a net margin of 15.92% and a return on equity of 298.80%. The business’s revenue for the quarter was up 6.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.75 EPS. As a group, equities analysts expect that Colgate-Palmolive will post 3.28 EPS for the current year.

In related news, CEO Noel R. Wallace sold 25,279 shares of the company’s stock in a transaction that occurred on Wednesday, May 5th. The stock was sold at an average price of $81.03, for a total transaction of $2,048,357.37. Following the completion of the transaction, the chief executive officer now owns 257,057 shares in the company, valued at $20,829,328.71. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Stephen I. Sadove sold 8,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 5th. The shares were sold at an average price of $81.30, for a total value of $650,400.00. Following the transaction, the director now owns 11,324 shares of the company’s stock, valued at approximately $920,641.20. The disclosure for this sale can be found here. Insiders sold 91,040 shares of company stock valued at $7,384,255 in the last quarter. Corporate insiders own 0.32% of the company’s stock.

CL has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $87.00 to $85.00 and set a “neutral” rating for the company in a report on Friday, April 16th. Deutsche Bank Aktiengesellschaft upped their target price on Colgate-Palmolive from $84.00 to $85.00 and gave the stock a “hold” rating in a research note on Monday, May 3rd. Credit Suisse Group raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and upped their target price for the stock from $80.00 to $95.00 in a research note on Wednesday. Finally, Zacks Investment Research raised Colgate-Palmolive from a “sell” rating to a “hold” rating and set a $85.00 target price for the company in a research note on Monday, May 3rd. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $84.42.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment's products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items.

Featured Article: What Does Beta Mean In Stock Selection?

Dividend History for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with's FREE daily email newsletter.